Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Alimera Sciences (ALIM) Short Interest Ratio & Short Volume

Alimera Sciences logo

Alimera Sciences Short Interest Data

Alimera Sciences (ALIM) has a short interest of 578,500 shares. This marks a -13.77% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 376,318 shares to cover all short positions.

Current Short Interest
578,500 shares
Previous Short Interest
670,900 shares
Change Vs. Previous Month
-13.77%
Dollar Volume Sold Short
$3.20 million
Short Interest Ratio
0.7 Days to Cover
Last Record Date
August 31, 2024
Outstanding Shares
52,389,000 shares
Percentage of Shares Shorted
1.10%
Today's Trading Volume
0 shares
Average Trading Volume
376,318 shares
Today's Volume Vs. Average
0%
Short Selling Alimera Sciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Alimera Sciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ALIM Short Interest Over Time

ALIM Days to Cover Over Time

ALIM Percentage of Float Shorted Over Time

Alimera Sciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/2024578,500 shares $3.20 million -13.8%N/A0.7 $5.53
8/15/2024670,900 shares $3.74 million +3.9%N/A1.7 $5.58
7/31/2024645,600 shares $3.59 million +4.6%N/A1.6 $5.56
7/15/2024617,100 shares $3.43 million +169.1%N/A1.9 $5.56
6/30/2024229,300 shares $1.27 million +142.1%N/A0.7 $5.56
6/15/202494,700 shares $300,199.00 -25.4%N/A0.4 $3.17
5/31/2024127,000 shares $387,350.00 +22.2%N/A1.3 $3.05
5/15/2024103,900 shares $339,753.00 -14.6%N/A1.5 $3.27
4/30/2024121,700 shares $447,856.00 +8.4%N/A1.7 $3.68
4/15/2024112,300 shares $397,542.00 +3.2%N/A1.6 $3.54
3/31/2024108,800 shares $424,320.00 +26.8%N/A1.3 $3.90
3/15/202485,800 shares $361,218.00 -27.7%N/A1 $4.21
2/29/2024118,600 shares $419,844.00 -57.2%N/A1.2 $3.54
2/15/2024276,800 shares $941,120.00 -9.2%N/A2.8 $3.40
1/31/2024304,900 shares $1.11 million -5.2%N/A3.6 $3.65
1/15/2024321,700 shares $1.25 million -6.7%N/A3.9 $3.89
12/31/2023344,600 shares $1.49 million +146.3%N/A4.7 $4.32
12/15/2023139,900 shares $559,600.00 -22.2%N/A2.1 $4.00
11/30/2023179,800 shares $554,683.00 +14.2%N/A4.3 $3.09
11/15/2023157,500 shares $518,175.00 +2.8%N/A4.2 $3.29
10/31/2023153,200 shares $513,220.00 +18.2%N/A3.9 $3.35
10/15/2023129,600 shares $340,848.00 +2.8%N/A3.4 $2.63
9/30/2023126,100 shares $390,910.00 -9.4%N/A3.3 $3.10
9/15/2023139,200 shares $462,144.00 +14.4%N/A3.2 $3.32
8/31/2023121,700 shares $400,393.00 -82.6%3.1%2.8 $3.29
8/15/2023697,400 shares $2.49 million +0.7%N/A11.2 $3.57
7/31/2023692,700 shares $2.36 million -1.2%10.1%1.1 $3.41
7/15/2023700,900 shares $2.63 million +0.9%10.8%1.1 $3.75
6/30/2023694,800 shares $2.03 million -3.4%10.7%1.1 $2.92
6/15/2023719,100 shares $2.04 million -9.2%12.9%1.2 $2.83
5/31/2023791,600 shares $2.18 million +3,157.6%14.4%1.3 $2.75
5/15/202324,300 shares $39,883.59 -10.7%0.4%0 $1.64
4/30/202327,200 shares $49,776.00 -7.8%0.5%1.2 $1.83
4/15/202329,500 shares $61,950.00 -29.8%0.6%1.3 $2.10
3/31/202342,000 shares $88,200.00 +87.5%0.8%1.8 $2.10
3/15/202322,400 shares $36,064.00 -2.2%0.4%1.9 $1.61
2/28/202322,900 shares $49,235.00 +2.2%0.4%1.4 $2.15
2/15/202322,400 shares $55,328.00 -10.0%0.4%1.5 $2.47
1/31/202324,900 shares $67,230.00 +15.8%0.5%1.6 $2.70
1/15/202321,500 shares $69,844.90 -9.7%0.4%1.5 $3.25
This Indicator called BOTH NVDA rallies (Ad)

Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is…

12/30/202223,800 shares $64,498.00 +6.3%0.4%1.7 $2.71
12/15/202222,400 shares $50,400.00 -1.3%0.4%1.8 $2.25
11/30/202222,700 shares $78,315.00 -2.2%0.4%2.4 $3.45
11/15/202223,200 shares $108,808.00 +12.1%0.4%2.6 $4.69
10/31/202220,700 shares $108,054.00 -4.2%0.4%2 $5.22
10/15/202221,600 shares $117,331.20 No Change0.4%1.5 $5.43
9/30/202221,600 shares $109,728.00 +1.9%0.4%1.5 $5.08
9/15/202221,200 shares $129,532.00 +3.9%0.4%1.4 $6.11
8/31/202220,400 shares $137,904.00 -15.0%0.4%1.3 $6.76
8/15/202224,000 shares $164,160.00 -4.4%0.5%1.3 $6.84
7/31/202225,100 shares $143,321.00 -9.4%0.5%1.2 $5.71
7/15/202227,700 shares $142,655.00 -3.8%0.5%1.5 $5.15
6/30/202228,800 shares $157,536.00 +0.4%0.5%1.5 $5.47
6/15/202228,700 shares $153,832.00 +3.2%0.5%1.2 $5.36
5/31/202227,800 shares $169,580.00 +15.8%0.5%1 $6.10
5/15/202224,000 shares $104,880.00 -13.0%0.5%0.9 $4.37
4/30/202227,600 shares $155,388.00 -20.0%0.5%1 $5.63
4/15/202234,500 shares $212,175.00 +17.0%0.7%0.8 $6.15
3/31/202229,500 shares $165,200.00 -13.2%0.6%0.7 $5.60
3/15/202234,000 shares $178,500.00 -29.6%0.7%0.9 $5.25
2/28/202248,300 shares $234,738.00 +19.3%0.9%1.3 $4.86
2/15/202240,500 shares $185,895.00 -6.7%0.8%1 $4.59
1/31/202243,400 shares $196,168.00 -17.0%0.9%0.8 $4.52
1/15/202252,300 shares $236,134.50 +61.4%1.0%0.9 $4.52
12/31/202132,400 shares $166,212.00 -11.2%0.6%0.5 $5.13
12/15/202136,500 shares $168,265.00 -22.8%0.7%0.5 $4.61
11/30/202147,300 shares $247,379.00 -75.7%0.9%0.7 $5.23
11/15/2021194,600 shares $1.13 million +15.5%3.8%2.4 $5.79
10/29/2021168,500 shares $744,770.00 +0.8%3.3%2 $4.42
10/15/2021167,100 shares $735,240.00 -5.1%3.3%3.5 $4.40
9/30/2021176,000 shares $742,720.00 +7.1%3.4%4.7 $4.22
9/15/2021164,400 shares $902,556.00 -11.1%3.2%4.9 $5.49
8/31/2021185,000 shares $1.11 million +9.9%3.7%6 $5.99
8/13/2021168,300 shares $1.23 million -2.5%3.4%8.8 $7.31
7/30/2021172,600 shares $1.52 million -6.8%3.5%11.8 $8.83
7/15/2021185,100 shares $1.65 million -1.1%3.8%8.9 $8.91
6/30/2021187,200 shares $1.70 million -26.4%3.8%5.9 $9.10
6/15/2021254,300 shares $2.62 million -4.0%5.2%6.7 $10.30
5/28/2021265,000 shares $2.78 million -5.6%5.4%5.1 $10.50
5/14/2021280,700 shares $2.42 million -2.1%6.2%4.6 $8.61
4/30/2021286,800 shares $2.94 million +20.5%6.3%3.4 $10.24
4/15/2021238,100 shares $2.61 million +107.6%4.8%2.8 $10.97
3/31/2021114,700 shares $1.12 million -2.4%2.3%1.3 $9.80
3/15/2021117,500 shares $1.33 million -13.5%2.4%1.3 $11.29
2/26/2021135,900 shares $1.08 million -1.7%2.8%1.5 $7.95
2/12/2021138,200 shares $1.14 million +1,324.7%2.8%1.5 $8.26
1/29/20219,700 shares $65,281.00 -54.9%0.2%0.1 $6.73
1/15/202121,500 shares $126,205.00 +74.8%0.4%0.3 $5.87
12/31/202012,300 shares $53,382.00 -26.8%0.3%0.2 $4.34
12/15/202016,800 shares $73,248.00 +7.0%0.4%0.3 $4.36
This Indicator called BOTH NVDA rallies (Ad)

Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is…

11/30/202015,700 shares $73,947.00 -25.9%0.4%0.5 $4.71
11/15/202021,200 shares $107,908.00 -32.3%0.5%0.7 $5.09
10/30/202031,300 shares $131,460.00 +23.2%0.7%1.1 $4.20
10/15/202025,400 shares $119,380.00 -19.4%0.6%0.6 $4.70
9/30/202031,500 shares $153,090.00 -15.6%0.7%0.7 $4.86
9/15/202037,300 shares $212,237.00 +10.4%0.8%0.8 $5.69
8/31/202033,800 shares $199,758.00 +53.6%0.8%0.6 $5.91
8/14/202022,000 shares $133,540.00 -2.7%0.5%0.4 $6.07
7/31/202022,600 shares $132,662.00 +123.8%0.6%0.5 $5.87
7/15/202010,100 shares $56,156.00 -16.5%0.3%0.4 $5.56
6/30/202012,100 shares $74,052.00 +266.7%0.3%0.5 $6.12
6/15/20203,300 shares $15,180.00 +37.5%0.1%0.1 $4.60
5/29/20202,400 shares $12,624.00 -41.5%0.1%0.2 $5.26
5/15/20204,100 shares $22,099.00 +64.0%0.1%0.1 $5.39
4/30/20202,500 shares $12,725.00 -37.5%0.1%0.1 $5.09
4/15/20204,000 shares $18,720.00 -20.0%0.1%0.1 $4.68
3/31/20205,000 shares $23,550.00 -75.6%0.1%0.1 $4.71
3/13/202020,500 shares $82,205.00 +9.0%0.5%0.5 $4.01
2/28/202018,800 shares $62,980.00 -25.7%0.5%0.3 $3.35
2/14/202025,300 shares $151,294.00 +11.5%0.6%0.5 $5.98
1/31/202022,700 shares $136,427.00 -28.8%0.6%0.4 $6.01
1/15/202031,900 shares $211,497.00 -57.0%0.8%0.4 $6.63
12/31/201974,100 shares $558,714.00 -17.5%1.9%1 $7.54

ALIM Short Interest - Frequently Asked Questions

What is Alimera Sciences' current short interest?

Short interest is the volume of Alimera Sciences shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 578,500 shares of ALIM short. Learn More on Alimera Sciences' current short interest.

What is a good short interest ratio for Alimera Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ALIM shares currently have a short interest ratio of 1.0. Learn More on Alimera Sciences's short interest ratio.

Is Alimera Sciences' short interest increasing or decreasing?

Alimera Sciences saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 578,500 shares, a decrease of 13.8% from the previous total of 670,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Alimera Sciences' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Alimera Sciences: Cogent Biosciences, Inc. (7.62%), Gyre Therapeutics, Inc. (2.53%), Collegium Pharmaceutical, Inc. (19.63%), ArriVent BioPharma, Inc. (17.02%), Avadel Pharmaceuticals plc (10.16%), Nuvation Bio Inc. (6.17%), Phibro Animal Health Co. (3.28%), Immatics (6.86%), Immunome, Inc. (19.29%), Poseida Therapeutics, Inc. (4.20%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks.

What does it mean to sell short Alimera Sciences stock?

Short selling ALIM is an investing strategy that aims to generate trading profit from Alimera Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Alimera Sciences?

A short squeeze for Alimera Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALIM, which in turn drives the price of the stock up even further.

How often is Alimera Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALIM, twice per month. The most recent reporting period available is August, 31 2024.




This page (NASDAQ:ALIM) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners